125 related articles for article (PubMed ID: 21082971)
21. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
Chiaretti S; Li X; Gentleman R; Vitale A; Wang KS; Mandelli F; Foà R; Ritz J
Clin Cancer Res; 2005 Oct; 11(20):7209-19. PubMed ID: 16243790
[TBL] [Abstract][Full Text] [Related]
22. Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement.
Baeumler J; Szuhai K; Falkenburg JH; van Schie ML; Ottmann OG; Nijmeijer BA
Cancer Genet Cytogenet; 2008 Aug; 185(1):37-42. PubMed ID: 18656692
[TBL] [Abstract][Full Text] [Related]
23. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
24. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
25. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
[TBL] [Abstract][Full Text] [Related]
26. Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.
Mullighan CG; Williams RT; Downing JR; Sherr CJ
Genes Dev; 2008 Jun; 22(11):1411-5. PubMed ID: 18519632
[TBL] [Abstract][Full Text] [Related]
27. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
[TBL] [Abstract][Full Text] [Related]
28. Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia.
Styczyński J; Wysocki M
Haematologia (Budap); 2002; 32(4):313-25. PubMed ID: 12803106
[TBL] [Abstract][Full Text] [Related]
29. Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises.
Izraeli S
Curr Opin Hematol; 2014 Jul; 21(4):289-96. PubMed ID: 24848770
[TBL] [Abstract][Full Text] [Related]
30. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G
Leukemia; 2010 Jan; 24(1):66-73. PubMed ID: 19759560
[TBL] [Abstract][Full Text] [Related]
31. Integrated analysis of gene copy number, copy neutral LOH, and microRNA profiles in adult acute lymphoblastic leukemia.
Ninomiya S; Tyybäkinoja A; Borze I; Räty R; Saarinen-Pihkala UM; Usvasalo A; Elonen E; Knuutila S
Cytogenet Genome Res; 2012; 136(4):246-55. PubMed ID: 22456238
[TBL] [Abstract][Full Text] [Related]
32. Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
Davidsson J; Paulsson K; Lindgren D; Lilljebjörn H; Chaplin T; Forestier E; Andersen MK; Nordgren A; Rosenquist R; Fioretos T; Young BD; Johansson B
Leukemia; 2010 May; 24(5):924-31. PubMed ID: 20237506
[TBL] [Abstract][Full Text] [Related]
33. Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.
Iacobucci I; Roberts KG
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34062932
[TBL] [Abstract][Full Text] [Related]
34. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
[TBL] [Abstract][Full Text] [Related]
35. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
Roberts KG; Li Y; Payne-Turner D; Harvey RC; Yang YL; Pei D; McCastlain K; Ding L; Lu C; Song G; Ma J; Becksfort J; Rusch M; Chen SC; Easton J; Cheng J; Boggs K; Santiago-Morales N; Iacobucci I; Fulton RS; Wen J; Valentine M; Cheng C; Paugh SW; Devidas M; Chen IM; Reshmi S; Smith A; Hedlund E; Gupta P; Nagahawatte P; Wu G; Chen X; Yergeau D; Vadodaria B; Mulder H; Winick NJ; Larsen EC; Carroll WL; Heerema NA; Carroll AJ; Grayson G; Tasian SK; Moore AS; Keller F; Frei-Jones M; Whitlock JA; Raetz EA; White DL; Hughes TP; Guidry Auvil JM; Smith MA; Marcucci G; Bloomfield CD; Mrózek K; Kohlschmidt J; Stock W; Kornblau SM; Konopleva M; Paietta E; Pui CH; Jeha S; Relling MV; Evans WE; Gerhard DS; Gastier-Foster JM; Mardis E; Wilson RK; Loh ML; Downing JR; Hunger SP; Willman CL; Zhang J; Mullighan CG
N Engl J Med; 2014 Sep; 371(11):1005-15. PubMed ID: 25207766
[TBL] [Abstract][Full Text] [Related]
36. [Mechanisms of drug resistance in acute lymphoblastic leukemia].
Inukai T
Rinsho Ketsueki; 2016; 57(10):2022-2028. PubMed ID: 27795510
[TBL] [Abstract][Full Text] [Related]
37. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Fielding AK
Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039
[TBL] [Abstract][Full Text] [Related]
38. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.
Kuiper RP; Schoenmakers EF; van Reijmersdal SV; Hehir-Kwa JY; van Kessel AG; van Leeuwen FN; Hoogerbrugge PM
Leukemia; 2007 Jun; 21(6):1258-66. PubMed ID: 17443227
[TBL] [Abstract][Full Text] [Related]
39. Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.
Ribera JM; García O; Fernández-Abellán P; Lavilla E; Bernal MT; González-Campos J; Brunet S; Monteserín MC; Montesinos P; Sarrá J; Calbacho M; Alvarez-Larrán A; Tormo M; Oriol A;
Br J Haematol; 2012 Nov; 159(4):485-8. PubMed ID: 22966847
[No Abstract] [Full Text] [Related]
40. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.
Okamoto R; Ogawa S; Nowak D; Kawamata N; Akagi T; Kato M; Sanada M; Weiss T; Haferlach C; Dugas M; Ruckert C; Haferlach T; Koeffler HP
Haematologica; 2010 Sep; 95(9):1481-8. PubMed ID: 20435627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
